ERMAFERMAFOTC
Loading
EBITDA Margin Over TimeContracting
Percentile Rank14
3Y CAGR-35.8%
5Y CAGR-5.5%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-35.8%/yr
vs +6.8%/yr prior
5Y CAGR
-5.5%/yr
Recent deceleration
Acceleration
-42.6pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM7.00%-56.2%
202415.99%+118.9%
20237.31%-72.3%
202226.41%-14.8%
202131.00%+232.9%
20209.31%-34.0%
201914.11%-30.5%
201820.30%-5.0%
201721.37%+167.5%
20167.99%-